Clinical Trials in Houston

Showing 14461-14480 of 17,885 trials

Characteristics of Cord Blood Immunologic Parameters of Infants <32 Weeks Gestation

NCT00524394

Infants in the NICU are at high risk for morbidity and mortality from infections of any onset. Diagnosis of these infections is imperfect at best. Patterns of inflammatory and regulatory proteins (cytokines \& chemokines, in addition to antigen detection on antibody secreting cells (ASC's)may provide a more accurate and rapid approach to diagnosis of infections in these high-risk patients.

Premature BirthSepsis

The University of Texas Health Science Center, Houston2 participantsStarted Aug 2007

Houston, Texas, United States

COMPLETEDPhase 1< 1 mile

A Phase I/Ib, Multicenter, Open-Label, Dose Escalation Study of E7080 in Patients With Solid Tumors and in Combination With Temozolomide in Patients With Advanced and/or Metastatic Melanoma

NCT00121680

The purpose of this study is to study the safety of E7080 administered to patients with solid tumors or lymphomas. Please note: this study is now recruiting patients with advanced and/or metastatic melanoma only. In the current phase of this study, To determine the MTD and the pharmacokinetic profile of E7080 when given as continuous daily (qd) dosing in combination with temozolomide.

Metastatic Melanoma

Eisai Inc.115 participantsStarted Jul 2005

Dallas, Texas, United States • Houston, Texas, United States

COMPLETEDPhase 3< 1 mile

An Efficacy and Safety Study of Trabectedin Versus Doxorubicin-Based Chemotherapy in Participants With Translocation-Related Sarcomas (TRS)

NCT00796120

The purpose of this study is to evaluate the efficacy and safety of trabectedin compared to standard doxorubicin in participants with advanced translocation-related sarcomas (cancer of connective tissue cells) (TRS).

Sarcoma

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.121 participantsStarted Nov 2008

Santa Monica, California, United States • Boston, Massachusetts, United States • Albuquerque, New Mexico, United States +18 more locations

Characteristics of Cord Blood Immunologic Parameters of Infants <32 Weeks Gestation

A Phase I/Ib, Multicenter, Open-Label, Dose Escalation Study of E7080 in Patients With Solid Tumors and in Combination With Temozolomide in Patients With Advanced and/or Metastatic Melanoma

An Efficacy and Safety Study of Trabectedin Versus Doxorubicin-Based Chemotherapy in Participants With Translocation-Related Sarcomas (TRS)

Find Trials by Condition in Houston

Safety Study of Umbilical Cord Blood To Treat Pediatric Traumatic Brain Injury

Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS)

AR08 for Treatment of ADHD in Children

Prehospital Resuscitation On Helicopter Study

Nuvigil in Treatment of Cancer-Related Fatigue in Chronic Myeloid Leukemia Patients

Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM

Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis

Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF

First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy

A Study to Evaluate the Efficacy and Safety of Alglucosidase Alfa Produced at the 4000 L Scale for Pompe Disease

Dose-Escalation Phase 1 Study of G-202 (Mipsagargin) in Patients With Advanced Solid Tumors

Natural History of Apparent Mineralocorticoid Excess Syndrome

A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis

Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.

The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events

Patient-Defined Treatment Success and Preferences in Stage IV Lung Cancer Patients